Status:
WITHDRAWN
Cascade PRFM Study: The Evaluation of Cascade Platelet-Rich Fibrin Matrix (PRFM) on Rotator Cuff Healing
Lead Sponsor:
Hospital for Special Surgery, New York
Collaborating Sponsors:
Musculoskeletal Transplant Foundation
Conditions:
Rotator Cuff
Tendon Injuries
Eligibility:
All Genders
45+ years
Phase:
PHASE3
Brief Summary
Hypothesis: The use of cascade platelet-rich fibrin matrix (PRFM) on medium and large sized rotator cuff tears will improve patient results versus the control results by 50%. The purpose of this stud...
Eligibility Criteria
Inclusion
- Patients 45 years of age and older who have failed conservative treatment for rotator cuff pathology.
- Patients in this study will have full thickness rotator cuff tears that are classified arthroscopically as medium (1 to 3 cm) or large (3 to 5 cm) and that are treated with arthroscopic repair.
Exclusion
- Patients who have undergone revision procedures, mini-open, or open procedures will be excluded.
Key Trial Info
Start Date :
January 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2005
Estimated Enrollment :
Patients enrolled
Trial Details
Trial ID
NCT00198185
Start Date
January 1 2005
End Date
January 1 2005
Last Update
January 4 2018
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital for Special Surgery
New York, New York, United States, 10021